Sangamo Therapeutics (SGMOQ) Tax Provisions (2015 - 2025)

Sangamo Therapeutics' Tax Provisions history runs 8 years deep, the most recent figure standing at -$553000.0 for Q4 2025.

• On a quarterly basis, Tax Provisions fell 29.51% year-over-year to -$553000.0 in Q4 2025; TTM through Dec 2025 was -$568000.0, a 240.12% decrease from a year earlier, with the FY2025 full-year figure at -$568000.0, down 240.12% from the prior year.
• Tax Provisions fell to -$553000.0 in Q4 2025 per SGMOQ's latest filing, from -$161000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $1.3 million in Q3 2023 and bottomed at -$6.3 million in Q2 2023.
• The 5-year median for Tax Provisions is $66000.0 (2022), against an average of -$254450.0.
• Biggest YoY gain for Tax Provisions was 4133.33% in 2023; the steepest drop was 7739.02% in 2023.
• Year by year, Tax Provisions stood at -$67000.0 in 2021, then surged by 441.79% to $229000.0 in 2022, then slumped by 218.78% to -$272000.0 in 2023, then slumped by 56.99% to -$427000.0 in 2024, then fell by 29.51% to -$553000.0 in 2025.
• Per Business Quant, the three latest SGMOQ Tax Provisions figures stand at -$553000.0 (Q4 2025), -$161000.0 (Q3 2025), and $27000.0 (Q2 2025).